biotech
Ipsen ends P3 trial on liver cancer early due to strong data
January 18, 2018Research and Development Cabometyx, Exelixis, biotech, drugs, ipsen, pharma, pharmaceutical
Ipsen and Exelixis, partners in developing Cabometyx (cabozantinib), have revealed that they have cut short a Phase 3 trial into …
Celgene rumoured to be revving up for Juno buyout
January 17, 2018Research and Development, Sales and Marketing CAR-T, Celgene, Juno, biotech, drugs, pharma, pharmaceutical
Celgene has already started off the year with a bang, announcing a deal with Impact Biomedicines worth a potential $7 …
Digital solutions from Veeva’s European Commercial & Medical Summit
January 17, 2018Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, veeva
When Peter Gassner, CEO and founder of Veeva, provided the keynote speech at the company’s European Commercial & Medical Summit, …
MSD’s interim Keytruda combo data spooks Roche and BMS
January 16, 2018Research and Development MSD, Merck, biotech, drugs, keytruda, pharma, pharmaceutical
When PD-1/L1 treatments first came on the market, there was a race to snaffle as many indications as possible for …
Hikma bring in new CSO
January 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hikma, biotech, drugs, pharma, pharmaceutical
Hikma Pharmaceuticals has announced that Surendera Tyagi is being brought in to join the company as Group Chief Scientific Officer …
Asthma carves $82 billion out of US economy every year
January 15, 2018Manufacturing and Production, Medical Communications asthma, biotech, drugs, pharma, pharmaceutical
A study created by researchers at the Centers for Disease Control and Prevention has estimated that asthma is costing the …
Seizing opportunities in the next steps for real world evidence
January 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Real world evidence is high on the agenda at many conferences, as people mull over the possibilities that it may …
Teva settles with Israeli authorities over international bribery
January 15, 2018Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical
Just over a year ago, Teva closed a case with US authorities by agreeing to pay a $519 million fine …
Sanofi agrees to reimburse Philippines’ Dengvaxia stockpiles
January 15, 2018Sales and Marketing Philippines, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi has agreed with the Department of Health (DoH) for the Philippines to reimburse $27.86 million worth of vaccines, though …
Universal flu vaccine receives Google’s financial backing
January 15, 2018Sales and Marketing Vaccine, biotech, drugs, flu, pharma, pharmaceutical
Vaccitech, a spin-out company from the University of Oxford, recently launched a Series A financing round and had some fairly …
FDA steps in to prohibit codeine cough syrups for children
January 12, 2018Medical Communications FDA, biotech, drugs, pharma, pharmaceutical
The FDA has announced that it will require all labels to state that cough syrups containing codeine or hydrocodone are …
Another Alzheimer’s drug bites the dust in P3
January 12, 2018Medical Communications, Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
It’s been a terrible week for Alzheimer’s disease research, after Pfizer shuttered its neuroscience unit and
Novartis prises Pfizer’s Oncology Head away
January 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Pfizer, biotech, drugs, pharma, pharmaceutical
Novartis has been looking to find someone to fill the shoes of Bruno Strigini since it was revealed that he …
Teva execs feel the pinch, after pay halved
January 11, 2018Medical Communications, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical
Teva’s current crisis is built upon problems that run deep into the company, after numerous acquisitions left it bloated and …
AIDS charity lambasts “ethically challenged” Gilead over price hikes
January 11, 2018Sales and Marketing AIDS, Gilead, HIV, Truvada, biotech, drugs, pharma, pharmaceutical
The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, …
Latest content
